Given the limitations associated with conventional cancer treatment options, there has been a surge in the need for more effective, safe and versatile alternatives, such as TIL-based therapies.
Driven by a promising development pipeline and encouraging clinical trial results, the TIL-based therapy market is likely to carve out a significant share of the cancer immunotherapy market. The financial opportunity within the TIL-based therapy market has been analyzed across the following segments:
- Target Indication(s)
- Melanoma
- Head and Neck Carcinoma
- Chronic Lymphocytic Leukemia
- Sarcoma
- Hepatocellular Carcinoma
- Breast Cancer
- Acute Myeloid Leukemia
- Cervical Carcinoma
- Key Geographical Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and North Africa
- Rest of the World
The Global TIL Therapy Market (2nd Edition), 2023-2035 report features the following companies, which we identified to be key players in this domain:
- Cellectis
- Cellular Biomedicine Group
- Iovance Biotherapeutics
- Lytix Biopharma
- Phio Pharmaceuticals
Table of Contents
- Preface
- Executive Summary
- Introduction
- TIL-based Therapies: Market Landscape
- Clinical Trial Analysis
- Key Opinion Leaders
- TIL-based Therapy Profiles
- Partnerships And Collaborations
- Funding And Investment Analysis
- Patent Analysis
- Case Study: Cell Therapy Manufacturing
- Cost Price Analysis
- Market Forecast and Opportunity Analysis
- Company Profiles
- Concluding Remarks
- Executive Insights
- Appendix I: Tabulated Data
- Appendix II: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/til-therapies-market.html
You may also be interested in the following titles:
Decentralized Clinical Trials / Virtual Clinical Trials Market |
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415